Bevacizumab Intravenous and Recombinate
Determining the interaction of Bevacizumab Intravenous and Recombinate and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: bevacizumab
Brand name: Avastin, Mvasi
Synonyms: Bevacizumab
Generic Name: antihemophilic factor
Brand name: Advate, Adynovate, Afstyla, Eloctate with Fc Fusion Protein, Helixate FS, Kogenate FS, Kovaltry, Novoeight, Nuwiq, Recombinate, Xyntha, Hemofil-M, Koate-DVI, Monoclate-P, Jivi, Obizur
Synonyms: Recombinate (recombinant)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Bevacizumab Intravenous-Recombinate recombinant
- Bevacizumab Intravenous-Recombivax
- Bevacizumab Intravenous-Recombivax HB
- Bevacizumab Intravenous-Recombivax HB Adult
- Bevacizumab Intravenous-Recombivax HB Dialysis Formulation
- Bevacizumab Intravenous-Recombivax HB Pediatric/Adolescent
- Recombinate-Bevacizumab-awwb
- Recombinate-Bevacizumab-awwb Intravenous
- Recombinate-Bevespi Aerosphere
- Recombinate-Bevyxxa
- Recombinate-Bexarotene
- Recombinate-Bexarotene (Systemic)